Mucinous adenocarcinoma arising from a residual supratentorial neurenteric cyst and expressing mutated KRAS : a case report

Malignant transformation of intracranial neurenteric cysts (NCs) has been reported in only 7 cases, but the molecular characteristics leading to malignant transformation remain unclear. A 61-year-old female presented with headache and dizziness. Imaging revealed a 10-cm, extra-axial cystic mass in b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human pathology 2016-12, Vol.58, p.146-151
Hauptverfasser: Rim, Hyun Taek, MD, Song, Joon Ho, MD, PhD, Kim, Eun Soo, MD, PhD, Kwon, Mi Jung, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 151
container_issue
container_start_page 146
container_title Human pathology
container_volume 58
creator Rim, Hyun Taek, MD
Song, Joon Ho, MD, PhD
Kim, Eun Soo, MD, PhD
Kwon, Mi Jung, MD, PhD
description Malignant transformation of intracranial neurenteric cysts (NCs) has been reported in only 7 cases, but the molecular characteristics leading to malignant transformation remain unclear. A 61-year-old female presented with headache and dizziness. Imaging revealed a 10-cm, extra-axial cystic mass in both middle fossae. A partial resection was performed, and the residual mass size gradually decreased. She had repeated ventriculoperitoneal shunts to relieve symptoms of hydrocephalus. Eight years later, follow-up images revealed marked enlargement of the mass and a newly developed lesion. After a second partial resection, a mucinous adenocarcinoma infiltrating the brain was identified. Transitions from benign-looking cuboidal cells to dysplastic cells were observed. A KRAS mutation, which might be associated with malignant NC transformation and was not present in the initial specimen, was identified in the adenocarcinoma. In conclusion, KRAS -mutant mucinous adenocarcinoma may arise in a longstanding residual NC after partial resection.
doi_str_mv 10.1016/j.humpath.2016.05.027
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1844353668</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0046817716301915</els_id><sourcerecordid>1844353668</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-c14768fa73c95bccc9302c69d8a3aa9d452acdc57248bfe322d4c728fa8914283</originalsourceid><addsrcrecordid>eNqFkktv1DAUhSMEokPhJ4AssWGT4GceLEBVRQFRhERhbXmub6iHxAl2jBjx5-swA0jdsLKO9J1jX59bFI8ZrRhl9fNddZ3G2SzXFc-yoqqivLlTbJgSvGxFx-8WG0plXbasaU6KBzHuKGVMSXW_OOGNqjvedZvi14cEzk8pEmPRT2DCKkdDTHDR-a-kD9NIDAkYnU1mIDHNwSzolym4LD2mkAUGBwT2cSHGW4I_58z_to9pybQl7z-dXZEXOQhMxJw2T2F5WNzrzRDx0fE8Lb5cvP58_ra8_Pjm3fnZZQmKtUsJTDZ125tGQKe2ANAJyqHubGuEMZ2VihuwoBou222PgnMroeHZ0XZM8lacFs8OuXOYvieMix5dBBwG4zFPrlkrpVCirlf06S10N6Xg8-tWqpGSUaUypQ4UhCnGgL2egxtN2GtG9dqO3uljO3ptR1OlczvZ9-SYnrYj2r-uP3Vk4NUBwPwdPxwGHcGhB7QuICzaTu6_V7y8lQCD8w7M8A33GP9NoyPXVF-tK7JuCKsFZV1enhuriLnQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1847441055</pqid></control><display><type>article</type><title>Mucinous adenocarcinoma arising from a residual supratentorial neurenteric cyst and expressing mutated KRAS : a case report</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Rim, Hyun Taek, MD ; Song, Joon Ho, MD, PhD ; Kim, Eun Soo, MD, PhD ; Kwon, Mi Jung, MD, PhD</creator><creatorcontrib>Rim, Hyun Taek, MD ; Song, Joon Ho, MD, PhD ; Kim, Eun Soo, MD, PhD ; Kwon, Mi Jung, MD, PhD</creatorcontrib><description>Malignant transformation of intracranial neurenteric cysts (NCs) has been reported in only 7 cases, but the molecular characteristics leading to malignant transformation remain unclear. A 61-year-old female presented with headache and dizziness. Imaging revealed a 10-cm, extra-axial cystic mass in both middle fossae. A partial resection was performed, and the residual mass size gradually decreased. She had repeated ventriculoperitoneal shunts to relieve symptoms of hydrocephalus. Eight years later, follow-up images revealed marked enlargement of the mass and a newly developed lesion. After a second partial resection, a mucinous adenocarcinoma infiltrating the brain was identified. Transitions from benign-looking cuboidal cells to dysplastic cells were observed. A KRAS mutation, which might be associated with malignant NC transformation and was not present in the initial specimen, was identified in the adenocarcinoma. In conclusion, KRAS -mutant mucinous adenocarcinoma may arise in a longstanding residual NC after partial resection.</description><identifier>ISSN: 0046-8177</identifier><identifier>EISSN: 1532-8392</identifier><identifier>DOI: 10.1016/j.humpath.2016.05.027</identifier><identifier>PMID: 27569299</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adenocarcinoma ; Adenocarcinoma, Mucinous - chemistry ; Adenocarcinoma, Mucinous - genetics ; Adenocarcinoma, Mucinous - pathology ; Adenocarcinoma, Mucinous - surgery ; Antigens ; Biomarkers ; Biomarkers, Tumor - analysis ; Biomarkers, Tumor - genetics ; Cell Transformation, Neoplastic - chemistry ; Cell Transformation, Neoplastic - genetics ; Cell Transformation, Neoplastic - pathology ; Cysts ; Deoxyribonucleic acid ; DNA ; DNA Mutational Analysis ; Female ; Humans ; Immunohistochemistry ; KRAS ; Magnetic Resonance Imaging ; Metastasis ; Middle Aged ; Mutation ; Neural Tube Defects - pathology ; Neural Tube Defects - surgery ; Neurenteric cyst ; NMR ; Nuclear magnetic resonance ; Pathology ; Proto-Oncogene Proteins p21(ras) - genetics ; Radiation therapy ; Recurrence ; Supratentorial Neoplasms - chemistry ; Supratentorial Neoplasms - genetics ; Supratentorial Neoplasms - pathology ; Supratentorial Neoplasms - surgery ; Surgery ; Time Factors</subject><ispartof>Human pathology, 2016-12, Vol.58, p.146-151</ispartof><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Dec 01, 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-c14768fa73c95bccc9302c69d8a3aa9d452acdc57248bfe322d4c728fa8914283</citedby><cites>FETCH-LOGICAL-c518t-c14768fa73c95bccc9302c69d8a3aa9d452acdc57248bfe322d4c728fa8914283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.humpath.2016.05.027$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27569299$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rim, Hyun Taek, MD</creatorcontrib><creatorcontrib>Song, Joon Ho, MD, PhD</creatorcontrib><creatorcontrib>Kim, Eun Soo, MD, PhD</creatorcontrib><creatorcontrib>Kwon, Mi Jung, MD, PhD</creatorcontrib><title>Mucinous adenocarcinoma arising from a residual supratentorial neurenteric cyst and expressing mutated KRAS : a case report</title><title>Human pathology</title><addtitle>Hum Pathol</addtitle><description>Malignant transformation of intracranial neurenteric cysts (NCs) has been reported in only 7 cases, but the molecular characteristics leading to malignant transformation remain unclear. A 61-year-old female presented with headache and dizziness. Imaging revealed a 10-cm, extra-axial cystic mass in both middle fossae. A partial resection was performed, and the residual mass size gradually decreased. She had repeated ventriculoperitoneal shunts to relieve symptoms of hydrocephalus. Eight years later, follow-up images revealed marked enlargement of the mass and a newly developed lesion. After a second partial resection, a mucinous adenocarcinoma infiltrating the brain was identified. Transitions from benign-looking cuboidal cells to dysplastic cells were observed. A KRAS mutation, which might be associated with malignant NC transformation and was not present in the initial specimen, was identified in the adenocarcinoma. In conclusion, KRAS -mutant mucinous adenocarcinoma may arise in a longstanding residual NC after partial resection.</description><subject>Adenocarcinoma</subject><subject>Adenocarcinoma, Mucinous - chemistry</subject><subject>Adenocarcinoma, Mucinous - genetics</subject><subject>Adenocarcinoma, Mucinous - pathology</subject><subject>Adenocarcinoma, Mucinous - surgery</subject><subject>Antigens</subject><subject>Biomarkers</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Cell Transformation, Neoplastic - chemistry</subject><subject>Cell Transformation, Neoplastic - genetics</subject><subject>Cell Transformation, Neoplastic - pathology</subject><subject>Cysts</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA Mutational Analysis</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>KRAS</subject><subject>Magnetic Resonance Imaging</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Neural Tube Defects - pathology</subject><subject>Neural Tube Defects - surgery</subject><subject>Neurenteric cyst</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Pathology</subject><subject>Proto-Oncogene Proteins p21(ras) - genetics</subject><subject>Radiation therapy</subject><subject>Recurrence</subject><subject>Supratentorial Neoplasms - chemistry</subject><subject>Supratentorial Neoplasms - genetics</subject><subject>Supratentorial Neoplasms - pathology</subject><subject>Supratentorial Neoplasms - surgery</subject><subject>Surgery</subject><subject>Time Factors</subject><issn>0046-8177</issn><issn>1532-8392</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkktv1DAUhSMEokPhJ4AssWGT4GceLEBVRQFRhERhbXmub6iHxAl2jBjx5-swA0jdsLKO9J1jX59bFI8ZrRhl9fNddZ3G2SzXFc-yoqqivLlTbJgSvGxFx-8WG0plXbasaU6KBzHuKGVMSXW_OOGNqjvedZvi14cEzk8pEmPRT2DCKkdDTHDR-a-kD9NIDAkYnU1mIDHNwSzolym4LD2mkAUGBwT2cSHGW4I_58z_to9pybQl7z-dXZEXOQhMxJw2T2F5WNzrzRDx0fE8Lb5cvP58_ra8_Pjm3fnZZQmKtUsJTDZ125tGQKe2ANAJyqHubGuEMZ2VihuwoBou222PgnMroeHZ0XZM8lacFs8OuXOYvieMix5dBBwG4zFPrlkrpVCirlf06S10N6Xg8-tWqpGSUaUypQ4UhCnGgL2egxtN2GtG9dqO3uljO3ptR1OlczvZ9-SYnrYj2r-uP3Vk4NUBwPwdPxwGHcGhB7QuICzaTu6_V7y8lQCD8w7M8A33GP9NoyPXVF-tK7JuCKsFZV1enhuriLnQ</recordid><startdate>20161201</startdate><enddate>20161201</enddate><creator>Rim, Hyun Taek, MD</creator><creator>Song, Joon Ho, MD, PhD</creator><creator>Kim, Eun Soo, MD, PhD</creator><creator>Kwon, Mi Jung, MD, PhD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20161201</creationdate><title>Mucinous adenocarcinoma arising from a residual supratentorial neurenteric cyst and expressing mutated KRAS : a case report</title><author>Rim, Hyun Taek, MD ; Song, Joon Ho, MD, PhD ; Kim, Eun Soo, MD, PhD ; Kwon, Mi Jung, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-c14768fa73c95bccc9302c69d8a3aa9d452acdc57248bfe322d4c728fa8914283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adenocarcinoma</topic><topic>Adenocarcinoma, Mucinous - chemistry</topic><topic>Adenocarcinoma, Mucinous - genetics</topic><topic>Adenocarcinoma, Mucinous - pathology</topic><topic>Adenocarcinoma, Mucinous - surgery</topic><topic>Antigens</topic><topic>Biomarkers</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Cell Transformation, Neoplastic - chemistry</topic><topic>Cell Transformation, Neoplastic - genetics</topic><topic>Cell Transformation, Neoplastic - pathology</topic><topic>Cysts</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA Mutational Analysis</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>KRAS</topic><topic>Magnetic Resonance Imaging</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Neural Tube Defects - pathology</topic><topic>Neural Tube Defects - surgery</topic><topic>Neurenteric cyst</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Pathology</topic><topic>Proto-Oncogene Proteins p21(ras) - genetics</topic><topic>Radiation therapy</topic><topic>Recurrence</topic><topic>Supratentorial Neoplasms - chemistry</topic><topic>Supratentorial Neoplasms - genetics</topic><topic>Supratentorial Neoplasms - pathology</topic><topic>Supratentorial Neoplasms - surgery</topic><topic>Surgery</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rim, Hyun Taek, MD</creatorcontrib><creatorcontrib>Song, Joon Ho, MD, PhD</creatorcontrib><creatorcontrib>Kim, Eun Soo, MD, PhD</creatorcontrib><creatorcontrib>Kwon, Mi Jung, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Human pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rim, Hyun Taek, MD</au><au>Song, Joon Ho, MD, PhD</au><au>Kim, Eun Soo, MD, PhD</au><au>Kwon, Mi Jung, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mucinous adenocarcinoma arising from a residual supratentorial neurenteric cyst and expressing mutated KRAS : a case report</atitle><jtitle>Human pathology</jtitle><addtitle>Hum Pathol</addtitle><date>2016-12-01</date><risdate>2016</risdate><volume>58</volume><spage>146</spage><epage>151</epage><pages>146-151</pages><issn>0046-8177</issn><eissn>1532-8392</eissn><abstract>Malignant transformation of intracranial neurenteric cysts (NCs) has been reported in only 7 cases, but the molecular characteristics leading to malignant transformation remain unclear. A 61-year-old female presented with headache and dizziness. Imaging revealed a 10-cm, extra-axial cystic mass in both middle fossae. A partial resection was performed, and the residual mass size gradually decreased. She had repeated ventriculoperitoneal shunts to relieve symptoms of hydrocephalus. Eight years later, follow-up images revealed marked enlargement of the mass and a newly developed lesion. After a second partial resection, a mucinous adenocarcinoma infiltrating the brain was identified. Transitions from benign-looking cuboidal cells to dysplastic cells were observed. A KRAS mutation, which might be associated with malignant NC transformation and was not present in the initial specimen, was identified in the adenocarcinoma. In conclusion, KRAS -mutant mucinous adenocarcinoma may arise in a longstanding residual NC after partial resection.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27569299</pmid><doi>10.1016/j.humpath.2016.05.027</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0046-8177
ispartof Human pathology, 2016-12, Vol.58, p.146-151
issn 0046-8177
1532-8392
language eng
recordid cdi_proquest_miscellaneous_1844353668
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adenocarcinoma
Adenocarcinoma, Mucinous - chemistry
Adenocarcinoma, Mucinous - genetics
Adenocarcinoma, Mucinous - pathology
Adenocarcinoma, Mucinous - surgery
Antigens
Biomarkers
Biomarkers, Tumor - analysis
Biomarkers, Tumor - genetics
Cell Transformation, Neoplastic - chemistry
Cell Transformation, Neoplastic - genetics
Cell Transformation, Neoplastic - pathology
Cysts
Deoxyribonucleic acid
DNA
DNA Mutational Analysis
Female
Humans
Immunohistochemistry
KRAS
Magnetic Resonance Imaging
Metastasis
Middle Aged
Mutation
Neural Tube Defects - pathology
Neural Tube Defects - surgery
Neurenteric cyst
NMR
Nuclear magnetic resonance
Pathology
Proto-Oncogene Proteins p21(ras) - genetics
Radiation therapy
Recurrence
Supratentorial Neoplasms - chemistry
Supratentorial Neoplasms - genetics
Supratentorial Neoplasms - pathology
Supratentorial Neoplasms - surgery
Surgery
Time Factors
title Mucinous adenocarcinoma arising from a residual supratentorial neurenteric cyst and expressing mutated KRAS : a case report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T22%3A02%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mucinous%20adenocarcinoma%20arising%20from%20a%20residual%20supratentorial%20neurenteric%20cyst%20and%20expressing%20mutated%20KRAS%20:%20a%20case%20report&rft.jtitle=Human%20pathology&rft.au=Rim,%20Hyun%20Taek,%20MD&rft.date=2016-12-01&rft.volume=58&rft.spage=146&rft.epage=151&rft.pages=146-151&rft.issn=0046-8177&rft.eissn=1532-8392&rft_id=info:doi/10.1016/j.humpath.2016.05.027&rft_dat=%3Cproquest_cross%3E1844353668%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1847441055&rft_id=info:pmid/27569299&rft_els_id=S0046817716301915&rfr_iscdi=true